Phase 2CompletedAge-related condition
Study to Determine Optimal Dose and Evaluate Safety, Tolerability, and Pharmacokinetics of Progerinin in Patients With Hutchinson-Gilford Progeria Syndrome (HGPS)
Progerinin, Lonafarnib in Hutchinson-Gilford Progeria Syndrome
PRG Science & Technology Co., Ltd. · 10 enrolled · NCT06775041 · updated 2 Oct 2026